» Articles » PMID: 29042935

Decreased Cathepsin K Levels in Human Atherosclerotic Plaques Are Associated with Plaque Instability

Overview
Journal Exp Ther Med
Specialty Pathology
Date 2017 Oct 19
PMID 29042935
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Investigating the determinants and dynamics of atherosclerotic plaque instability is a key area of current cardiovascular research. Extracellular matrix degradation from excessive proteolysis induced by enzymes such as cathepsin K (Cat K) is implicated in the pathogenesis of unstable plaques. The current study assessed the expression of Cat K in human unstable atherosclerotic plaques. Specimens of popliteal arteries with atherosclerotic plaques were classified as stable (<40% lipid core plaque area; n=6) or unstable (≥40% lipid core plaque area; n=14) based on histopathological examinations of hematoxylin and eosin stained sections. The expression of Cat K and cystatin C (Cys C) were assessed by immunohistochemical examination and levels of Cat K mRNA were detected by semi-quantitative reverse transcriptase polymerase chain reaction. Morphological changes including a larger lipid core, endothelial proliferation with foam cells and destruction of internal elastic lamina were observed in unstable atherosclerotic plaques. In unstable plaques, the expression of Cat K protein and mRNA was upregulated, whereas Cys C protein expression was downregulated. The interplay between Cat K and Cys C may underlie the progression of plaques from stable to unstable and the current study indicated that Cat K and Cys C are potential targets for preventing and treating vulnerable atherosclerotic plaque ruptures.

Citing Articles

Vascular Extracellular Matrix in Atherosclerosis.

Di Nubila A, Dilella G, Simone R, Barbieri S Int J Mol Sci. 2024; 25(22).

PMID: 39596083 PMC: 11594217. DOI: 10.3390/ijms252212017.


Overview of multifunctional cysteinyl cathepsins in atherosclerosis-based cardiovascular disease: from insights into molecular functions to clinical implications.

Cheng X, Narisawa M, Wang H, Piao L Cell Biosci. 2023; 13(1):91.

PMID: 37202785 PMC: 10197855. DOI: 10.1186/s13578-023-01040-4.


Inflammatory endothelium-targeted and cathepsin responsive nanoparticles are effective against atherosclerosis.

Fang F, Ni Y, Yu H, Yin H, Yang F, Li C Theranostics. 2022; 12(9):4200-4220.

PMID: 35673565 PMC: 9169363. DOI: 10.7150/thno.70896.


MiR-32-3p Regulates Myocardial Injury Induced by Microembolism and Microvascular Obstruction by Targeting RNF13 to Regulate the Stability of Atherosclerotic Plaques.

Huang D, Liu Y, Gao L, Wei X, Xu Y, Cai R J Cardiovasc Transl Res. 2021; 15(1):143-166.

PMID: 34185281 DOI: 10.1007/s12265-021-10150-8.


Unraveling the Role of Epicardial Adipose Tissue in Coronary Artery Disease: Partners in Crime?.

Conceicao G, Martins D, Miranda I, Leite-Moreira A, Vitorino R, Falcao-Pires I Int J Mol Sci. 2020; 21(22).

PMID: 33238643 PMC: 7700147. DOI: 10.3390/ijms21228866.


References
1.
Silvestre-Roig C, de Winther M, Weber C, Daemen M, Lutgens E, Soehnlein O . Atherosclerotic plaque destabilization: mechanisms, models, and therapeutic strategies. Circ Res. 2014; 114(1):214-26. DOI: 10.1161/CIRCRESAHA.114.302355. View

2.
Rathore S, Terashima M, Matsuo H, Kinoshita Y, Kimura M, Tsuchikane E . Association of coronary plaque composition and arterial remodelling: a optical coherence tomography study. Atherosclerosis. 2012; 221(2):405-15. DOI: 10.1016/j.atherosclerosis.2011.10.018. View

3.
Novinec M, Lenarcic B . Cathepsin K: a unique collagenolytic cysteine peptidase. Biol Chem. 2013; 394(9):1163-79. DOI: 10.1515/hsz-2013-0134. View

4.
Samokhin A, Wong A, Saftig P, Bromme D . Role of cathepsin K in structural changes in brachiocephalic artery during progression of atherosclerosis in apoE-deficient mice. Atherosclerosis. 2008; 200(1):58-68. DOI: 10.1016/j.atherosclerosis.2007.12.047. View

5.
Shah P . Biomarkers of plaque instability. Curr Cardiol Rep. 2014; 16(12):547. DOI: 10.1007/s11886-014-0547-7. View